191 related articles for article (PubMed ID: 37691996)
1. Natamycin interferes with ergosterol-dependent lipid phases in model membranes.
Akkerman V; Scheidt HA; Reinholdt P; Bashawat M; Szomek M; Lehmann M; Wessig P; Covey DF; Kongsted J; Müller P; Wüstner D
BBA Adv; 2023; 4():100102. PubMed ID: 37691996
[TBL] [Abstract][Full Text] [Related]
2. Natamycin sequesters ergosterol and interferes with substrate transport by the lysine transporter Lyp1 from yeast.
Szomek M; Reinholdt P; Walther HL; Scheidt HA; Müller P; Obermaier S; Poolman B; Kongsted J; Wüstner D
Biochim Biophys Acta Biomembr; 2022 Nov; 1864(11):184012. PubMed ID: 35914570
[TBL] [Abstract][Full Text] [Related]
3. Recognition of Membrane Sterols by Polyene Antifungals Amphotericin B and Natamycin, A (13)C MAS NMR Study.
Ciesielski F; Griffin DC; Loraine J; Rittig M; Delves-Broughton J; Bonev BB
Front Cell Dev Biol; 2016; 4():57. PubMed ID: 27379235
[TBL] [Abstract][Full Text] [Related]
4. Ergosterol promotes aggregation of natamycin in the yeast plasma membrane.
Szomek M; Akkerman V; Lauritsen L; Walther HL; Juhl AD; Thaysen K; Egebjerg JM; Covey DF; Lehmann M; Wessig P; Foster AJ; Poolman B; Werner S; Schneider G; Müller P; Wüstner D
Biochim Biophys Acta Biomembr; 2024 May; 1866(7):184350. PubMed ID: 38806103
[TBL] [Abstract][Full Text] [Related]
5. Natamycin blocks fungal growth by binding specifically to ergosterol without permeabilizing the membrane.
te Welscher YM; ten Napel HH; Balagué MM; Souza CM; Riezman H; de Kruijff B; Breukink E
J Biol Chem; 2008 Mar; 283(10):6393-401. PubMed ID: 18165687
[TBL] [Abstract][Full Text] [Related]
6. Modulation of amphotericin B membrane interaction by cholesterol and ergosterol--a molecular dynamics study.
Czub J; Baginski M
J Phys Chem B; 2006 Aug; 110(33):16743-53. PubMed ID: 16913814
[TBL] [Abstract][Full Text] [Related]
7. Interaction of the polyene antibiotic etruscomycin with large unilamellar lipid vesicles: binding and proton permeability inducement.
Capuozzo E; Bolard J
Biochim Biophys Acta; 1985 Oct; 820(1):63-73. PubMed ID: 2996598
[TBL] [Abstract][Full Text] [Related]
8. Formulation and antifungal performance of natamycin-loaded liposomal suspensions: the benefits of sterol-enrichment.
Bouaoud C; Lebouille JG; Mendes E; De Braal HE; Meesters GM
J Liposome Res; 2016; 26(2):103-12. PubMed ID: 26009272
[TBL] [Abstract][Full Text] [Related]
9. Morphology and dynamics of domains in ergosterol or cholesterol containing membranes.
Galván-Hernández A; Kobayashi N; Hernández-Cobos J; Antillón A; Nakabayashi S; Ortega-Blake I
Biochim Biophys Acta Biomembr; 2020 Feb; 1862(2):183101. PubMed ID: 31672540
[TBL] [Abstract][Full Text] [Related]
10. Natamycin inhibits vacuole fusion at the priming phase via a specific interaction with ergosterol.
te Welscher YM; Jones L; van Leeuwen MR; Dijksterhuis J; de Kruijff B; Eitzen G; Breukink E
Antimicrob Agents Chemother; 2010 Jun; 54(6):2618-25. PubMed ID: 20385867
[TBL] [Abstract][Full Text] [Related]
11. The structuring effects of amphotericin B on pure and ergosterol- or cholesterol-containing dipalmitoylphosphatidylcholine bilayers: a differential scanning calorimetry study.
Fournier I; Barwicz J; Tancrède P
Biochim Biophys Acta; 1998 Aug; 1373(1):76-86. PubMed ID: 9733926
[TBL] [Abstract][Full Text] [Related]
12. Molecular order and dynamics of phosphatidylcholine bilayer membranes in the presence of cholesterol, ergosterol and lanosterol: a comparative study using 2H-, 13C- and 31P-NMR spectroscopy.
Urbina JA; Pekerar S; Le HB; Patterson J; Montez B; Oldfield E
Biochim Biophys Acta; 1995 Sep; 1238(2):163-76. PubMed ID: 7548131
[TBL] [Abstract][Full Text] [Related]
13. Role of the sterol superlattice in the partitioning of the antifungal drug nystatin into lipid membranes.
Wang MM; Sugar IP; Chong PL
Biochemistry; 1998 Aug; 37(34):11797-805. PubMed ID: 9718302
[TBL] [Abstract][Full Text] [Related]
14. The effect of ergosterol on dipalmitoylphosphatidylcholine bilayers: a deuterium NMR and calorimetric study.
Hsueh YW; Gilbert K; Trandum C; Zuckermann M; Thewalt J
Biophys J; 2005 Mar; 88(3):1799-808. PubMed ID: 15596499
[TBL] [Abstract][Full Text] [Related]
15. On the possibility of the amphotericin B-sterol complex formation in cholesterol- and ergosterol-containing lipid bilayers: a molecular dynamics study.
Neumann A; Czub J; Baginski M
J Phys Chem B; 2009 Dec; 113(48):15875-85. PubMed ID: 19929013
[TBL] [Abstract][Full Text] [Related]
16. Investigation of polyene macrolide antibiotic-induced permeability changes in vesicles by 31P nuclear magnetic resonance.
Pierce HD; Unrau AM; Oehlschlager AC
Can J Biochem; 1978 Aug; 56(8):801-7. PubMed ID: 688066
[TBL] [Abstract][Full Text] [Related]
17. Comparative molecular dynamics study of lipid membranes containing cholesterol and ergosterol.
Czub J; Baginski M
Biophys J; 2006 Apr; 90(7):2368-82. PubMed ID: 16399829
[TBL] [Abstract][Full Text] [Related]
18. The fluorescent cholesterol analog dehydroergosterol induces liquid-ordered domains in model membranes.
Garvik O; Benediktson P; Simonsen AC; Ipsen JH; Wüstner D
Chem Phys Lipids; 2009 Jun; 159(2):114-8. PubMed ID: 19477318
[TBL] [Abstract][Full Text] [Related]
19. Biophysical properties of ergosterol-enriched lipid rafts in yeast and tools for their study: characterization of ergosterol/phosphatidylcholine membranes with three fluorescent membrane probes.
Bastos AE; Marinho HS; Cordeiro AM; de Soure AM; de Almeida RF
Chem Phys Lipids; 2012 Jul; 165(5):577-88. PubMed ID: 22705749
[TBL] [Abstract][Full Text] [Related]
20. Effect of the polar head structure of polyene macrolide antifungal antibiotics on the mode of permeabilization of ergosterol- and cholesterol-containing lipidic vesicles studied by 31P-NMR.
Cybulska B; Herve M; Borowski E; Gary-Bobo CM
Mol Pharmacol; 1986 Mar; 29(3):293-8. PubMed ID: 3951434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
